Requirement for Comprehensive Pharmaceutical and Medical/Surgical Commercial Sales Data

This Request for Information (RFI) is for planning purposes only and is not a Request for Proposal (RFP), Invitation for Bid (IFB), or an obligation on the part of the Government to acquire any products or services. Responses to this RFI are not offers and cannot be accepted by the Government to form a binding contract. The Government reserves the right to determine how it should proceed as a result of this notice. Furthermore, those who respond to this RFI should not anticipate feedback with regard to its submission. The Government will not pay any cost incurred in response to this RFI. All costs associated with responding to this RFI will be solely at the responding party's expense. The information provided in this RFI is subject to change and is not binding on the Government. Background: Department of Defense medical readiness planners assess the readiness posture of an item, group of items, project or program. The ability to view Services' requirements and report on the commercial sector's ability to provide materiel to meet those requirements is essential. The Readiness Management Application (RMA) will be the source for accumulating disparate data to effectively determine what materiel can be used to meet the Services' requirements. The purchase of commercial sales data for all medical product lines will be an integral part of RMA's success. Objective/Scope: The intent of this requirement is purchase comprehensive commercial sales data, collected on monthly basis over the most recent 24-month period, for all pharmaceutical and medical/surgical products in order to provide visibility and insight into what medical materiel is being sold in the commercial side of the medical healthcare industry. The intent is to gather all pharmaceutical and medical/surgical commercial sales data available. DLA is contracting for the licensing of both pharmaceutical sales data and medical/surgical sales data as well as supporting data, such as product synonym files and packaging information necessary to maximize the usefulness of the commercial sales data. The data required by DLA shall include manufacturer names, full manufacturer catalog numbers, National Drug Codes (NDCs) for pharmaceuticals, monthly sales by product, monthly sales by product packaging configuration, and any synonyms for the commercial product (e.g. if the catalog number changed). It is the intent of the Government to assimilate all of the supplier's pharmaceutical and medical surgical commercial sales data into DLA Troop Support's suite of computer systems applications that support medical logistics readiness. The supplier will be responsible for assisting the Government in assimilating this data into the Government's readiness applications.